Quest Diagnostics to Speak at the Jefferies Healthcare Services Conference

Quest Diagnostics (NYSE:DGX), a diagnostic information services leader, announced that Executive Vice President and CFO Sam Samad will participate in the Jefferies Healthcare Services Conference in Nashville.

Rhea-AI Summary

Quest Diagnostics (NYSE:DGX), a diagnostic information services leader, announced that Executive Vice President and CFO Sam Samad will participate in the Jefferies Healthcare Services Conference in Nashville. The presentation is scheduled for September 29, 2025, at 4:35 p.m. ET.

The fireside chat and Q&A session will be available via live webcast on Quest's investor relations website. An archived version will be accessible within 24 hours after the event until October 24, 2025.

Argus Sep 16 session

-0.25% close to close Open Argus

Details

News Market Reaction – DGX

On Sep 16, the first trading day after this news, DGX closed 0.25% below the previous close.

Data tracked by StockTitan Argus for the Sep 16 session.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SECAUCUS, N.J., Sept. 15, 2025 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), a leader in diagnostic information services, today announced that Sam Samad, Executive Vice President and Chief Financial Officer, will speak on the company's strategy, performance and the latest market developments and trends during the Jefferies Healthcare Services Conference in Nashville on Monday, September 29, 2025, at 4:35 p.m. Eastern Time.

The fireside chat and Q&A session will be webcast live during the conference on the company's investor relations page, which can be accessed at ir.QuestDiagnostics.com. In addition, the archived webcast will be available within 24 hours after the conclusion of the live event and will remain available until October 24, 2025.

About Quest Diagnostics
Quest Diagnostics works across the healthcare ecosystem to create a healthier world, one life at a time. We provide diagnostic insights from the results of our laboratory testing to empower people, physicians and organizations to take action to improve health outcomes. Derived from one of the world's largest databases of de-identifiable clinical lab results, Quest's diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve healthcare management. Quest Diagnostics annually serves one in three adult Americans and half the physicians and hospitals in the United States, and our more than 55,000 employees understand that, in the right hands and with the right context, our diagnostic insights can inspire actions that transform lives and create a healthier world. www.QuestDiagnostics.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/quest-diagnostics-to-speak-at-the-jefferies-healthcare-services-conference-302556883.html

SOURCE Quest Diagnostics

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When is Quest Diagnostics (DGX) presenting at the Jefferies Healthcare Conference 2025?

Quest Diagnostics will present on Monday, September 29, 2025, at 4:35 p.m. Eastern Time in Nashville.

Who will represent Quest Diagnostics at the Jefferies Healthcare Conference?

Sam Samad, Quest Diagnostics' Executive Vice President and Chief Financial Officer, will represent the company.

How can investors access Quest Diagnostics' Jefferies conference presentation?

Investors can access the live webcast on Quest's investor relations website at ir.QuestDiagnostics.com. The archived webcast will be available for viewing until October 24, 2025.

What topics will Quest Diagnostics discuss at the Jefferies Healthcare Conference?

The presentation will cover Quest Diagnostics' company strategy, performance, and the latest market developments and trends in a fireside chat and Q&A format.